Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose
Clinical trial NCT01300988 · COMPLETED
Trial details
- NCT number
- NCT01300988
- Sponsor
- University of Pennsylvania
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Primary completion
- 2013-08-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.